The Melanoma Research Alliance (MRA) announces its eighth annual Request for Proposals (RFP), soliciting translational research grant applications from scientists and clinicians around the world. The RFP calls for ideas that could lead to high impact near-term clinical application in melanoma detection, prevention, diagnosis, staging, or treatment. MRA will accept proposals for Established Investigator Awards, Pilot Awards, Young Investigator Awards, Academic-Industry Partnership Awards (Established Investigator and Teams), and Special Opportunity Awards. Several special opportunities are being made possible in collaboration with Amgen, Bristol-Myers Squibb (BMS), and the Society for Immunotherapy of Cancer (SITC). In addition, we are pleased to announce a Young Investigator award in Dermatology. During this cycle, MRA plans to award at least $7 million to new projects.
Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma.
The RFP can be accessed below.
Please note the following key deadlines:
- November 11, 2014: Young Investigator Award (including Dermatology Young Investigators), Established Investigator Award (including BMS-MRA Established Investigators), and Pilot Award (including SITC-MRA Pilot Award) proposals are due.
- November 21, 2014: All Academic-Industry Partnership Award (for Established Investigators and Teams) and BMS-MRA Team Science Award proposals are due.
Full descriptions of each opportunity, including eligibility criteria and deadlines can be found in the RFP document below. This opportunity is closed.
Questions: Laura Brockway-Lunardi, Ph.D., MRA Scientific Program Director, email@example.com